These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21565431)

  • 1. [Lacosamide, new antiepileptic with broad perspectives].
    Gutiérrez-Álvarez AM; Sagarra-Mur D; Jiménez-Corral C
    Neurologia; 2011 Nov; 26(9):568-9. PubMed ID: 21565431
    [No Abstract]   [Full Text] [Related]  

  • 2. Lacosamide use in refractory idiopathic primary generalized epilepsy.
    Zangaladze A; Skidmore C
    Epilepsy Behav; 2012 Jan; 23(1):79-80. PubMed ID: 22197124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacosamide, a newer antiepileptic.
    Patyar S; Medhi B
    Neurosciences (Riyadh); 2010 Jan; 15(1):3-6. PubMed ID: 20677583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the right dose of lacosamide in pediatric patients with intractable epilepsy?
    Vishwanath VA; Miller LM
    Epilepsy Behav; 2012 Mar; 23(3):396-7. PubMed ID: 22381391
    [No Abstract]   [Full Text] [Related]  

  • 5. Lacosamide in patients with pharmacoresistant epilepsy.
    Verrotti A; Loiacono G; Olivieri C; Zulli E; Zaccara G
    Expert Opin Pharmacother; 2012 Oct; 13(14):2065-72. PubMed ID: 22873760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial post marketing experience with lacosamide in adult patients with epilepsy.
    Harden CL; Cohn A; Lowe M; Serrano E
    Epilepsy Res; 2012 Feb; 98(2-3):260-3. PubMed ID: 22015002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine.
    Belcastro V; Arnaboldi M; Taborelli A; Prontera P
    Epilepsy Behav; 2011 Mar; 20(3):589-90. PubMed ID: 21367668
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lacosamide--oral administration (Vimpat) ].
    Duh D; Peeters S
    J Pharm Belg; 2011 Mar; (1):25-6. PubMed ID: 21473129
    [No Abstract]   [Full Text] [Related]  

  • 9. A high-performance liquid chromatography assay to monitor the new antiepileptic drug lacosamide in patients with epilepsy.
    Greenaway C; Ratnaraj N; Sander JW; Patsalos PN
    Ther Drug Monit; 2010 Aug; 32(4):448-52. PubMed ID: 20386357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany.
    Wehner T; Bauer S; Hamer HM; Hattemer K; Immisch I; Knake S; Nowak M; Reif PS; Strzelczyk A; Rosenow F
    Epilepsy Behav; 2009 Nov; 16(3):423-5. PubMed ID: 19767242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Well-Tolerated and Effective Antiepileptic Drug for Patients With Myasthenia Gravis at Last?
    Sánchez-Villalobos JM; Villegas-Martínez I; Pérez-Vicente JA
    Clin Neuropharmacol; 2018; 41(2):80-81. PubMed ID: 29432285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiepileptic drug lacosamide(vimpat)].
    Zenkov LR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):72-9. PubMed ID: 21510453
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
    Tilz C; Resch R; Hofer T; Eggers C
    Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacosamide-induced rash.
    Koubeissi MZ; Vismer M; Ehrlich A
    Epileptic Disord; 2014 Sep; 16(3):380-3. PubMed ID: 25035958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lacosamide: a new generation in the treatment of epilepsy].
    Gil-Nagel A; Marin H
    Rev Neurol; 2011 Feb; 52(3):159-62. PubMed ID: 21287492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does lacosamide aggravate Lennox-Gastaut syndrome? Report on three consecutive cases.
    Cuzzola A; Ferlazzo E; Italiano D; Calabrò RS; Bramanti P; Genton P
    Epilepsy Behav; 2010 Dec; 19(4):650-1. PubMed ID: 20970386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
    Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
    Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?
    Novy J; Patsalos PN; Sander JW; Sisodiya SM
    Epilepsy Behav; 2011 Jan; 20(1):20-3. PubMed ID: 21056937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of antiepileptic drugs during pregnancy.
    Hunt SJ; Morrow JI
    Expert Opin Drug Saf; 2005 Sep; 4(5):869-77. PubMed ID: 16111449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacosamide: new adjunctive treatment option for partial-onset seizures.
    Chung SS
    Expert Opin Pharmacother; 2010 Jun; 11(9):1595-602. PubMed ID: 20482307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.